BGMS: cyclacel.com Net earnings per share for the last 12 months

Symbol and logo of brand Bio Green Med Solution (BGMS)

The current EPS TTM level clearly demonstrates the financial results of Bio Green Med Solution Inc, while -2.39 captures the magnitude of this parameter. The developer faces a dependence on external funding and a lack of sales. However, ownership of patents for cell cycle regulation creates a valuation base. Currently, the startup is scaling its kinase inhibitor portfolio through a strategic alliance with pharma behemoths.

BGMS (Bio Green Med Solution Inc) Net earnings per share (EPS TTM) history from 09/13/2025 to 11/15/2026

Analytical breakdowns for Bio Green Med Solution Inc

- share price and expert price forecast:
Stock Quotes Bio Green Med Solution|BGMS - Fair Value Consensus
- market capitalization information:
Market Valuation Bio Green Med Solution Inc|BGMS - Aggregate Business Value
- balance sheet net asset value indicators:
Book Value per Share Bio Green Med Solution|BGMS - Book Capitalization|Market Value to Book Value Ratio cyclacel.com|BGMS - Aggregate Asset Value
- business debt structure and liquidity details:
Total Debt to Capital Bio Green Med Solution Inc|BGMS - Long-Term Indebtedness to Equity|Short-Term Debt to Capital Bio Green Med Solution Inc.|BGMS - Company Cumulative Debt|Debt to Book Value Bio Green Med Solution Inc|BGMS - Amount of Long-Term Liabilities|Company Short-Term Debts Bio Green Med Solution|Quick Ratio cyclacel.com
- net income and valuation multiples indicators:
BGMS - Company Profit|Future Profit Bio Green Med Solution Inc|BGMS - Company Value to Net Income|Projected Price to Earnings Bio Green Med Solution|BGMS - Company Value to Earnings Growth Ratio|EV/EBITDA Multiple Cyclacel|BGMS - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Bio Green Med Solution|BGMS - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months cyclacel.com|BGMS - Earnings per share increase in current year|Earnings growth forecast for next year Bio Green Med Solution Inc
- sales and revenue data:
BGMS - Revenue and Sales Volume|Company Projected Revenue Bio Green Med Solution Inc|BGMS - Price-to-Sales Ratio|Forward Price-to-Revenue Multiple Bio Green Med Solution Inc|BGMS - Trailing Twelve Months Revenue Growth
Basic company analysis:Bio Green Med Solution Inc - BGMS
Manufactured products of Bio Green Med Solution Inc.

The business stability of Bio Green Med Solution Inc. (BGMS) depends on the successful implementation of automation in oncology diagnostics. This indicator reflects the proportional income, calculated as the ratio of net profit to the total number of shares for the year. By analyzing the 12-month net income per share trend, an investor tracks the actual efficiency of capitalization. Growth in this metric confirms the scaling of software robots, which allows for an objective determination of the issuer's fair value.

Who Bio Green Med Solution Inc competes with

GMAB: Net earnings per share for the last 12 months|Earnings per share for the trailing year EXEL (Exelixis Corp)|NUVL (Nuvalent) - Net earnings per share for the last 12 months|KYMR: Earnings per share for the last four quarters|IDYA (IDEAYA Corp) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) enliventherapeutics.com|Earnings per share for the last twelve months ORIC Pharmaceuticals, Inc. (ORIC)|RLAY (Relay Therapeutics, Inc.) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) NRIX (Nurix Therapeutics Inc)|Net earnings per share for the trailing year Tyra Bio|Verastem Oncology - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Monte Rosa Therapeutics, Inc.|CGEM (Cullinan Therapeutics) - Net earnings per share for the last 12 months|IMRX: Earnings per share for the last four quarters|CCCC (c4therapeutics.com) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Black Diamond Therapeutics Inc. BDTX|Net earnings per share (EPS TTM) RPTX|PMV Pharmaceuticals, Inc. - Earnings per share for the last 12 months|Karyopharm Therapeutics - Net earnings per share for the last 12 months|Earnings per share for the trailing year PPCB|AADI: Net earnings per share for the last 12 months|aileronrx.com - Earnings per share for the last four quarters|BPMC: Net earnings per share (EPS TTM)|GlycoMimetics Inc. - Earnings per share for the trailing year|SWTX (SpringWorks Therapeutics, Inc) - Net earnings per share (EPS TTM)